Natera, Inc, a global leader in cell-free DNA and genetic testing, and MyOme, a leading clinical whole genome analysis and polygenic risk modeling company,...
MyOme, a clinical whole genome platform analysis company, announced that the company has raised $23 million in an oversubscribed series B financing round led...